Press-release for stocks related to nasdaq

Prices are updated after-hours

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNPX | $4.56 -0.22% 0.65% 14K

| -0.22% | O: 0.22% H: 2.4% C: -0.44%
nasdaq for

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 18, 2024
Published: 2024-04-18 (Crawled : 20:00) - biospace.com/
SDGR | $24.04 -3.1% -3.2% 570K

| -3.99% | O: 0.38% H: 0.0% C: 0.0%
nasdaq grants

bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $0.9229 -4.91% -4.66% 14K

| -22.69% | O: 1.68% H: 1.65% C: -4.13%
nasdaq grants

BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule - April 11, 2024
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
BCLI A | $0.545 3.81% 1.67% 2.8K

| -6.94% | O: -0.17% H: 13.56% C: -2.19%
nasdaq cell therapeutics market

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | $24.02 -1.64% -1.75% 320K

| -6.17% | O: -0.35% H: 1.98% C: 1.25%
nasdaq pharmaceuticals grants

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 10, 2024
Published: 2024-04-10 (Crawled : 12:00) - biospace.com/
BBIO | $25.03 -1.69% -1.76% 0

| -12.05% | O: -4.11% H: 0.81% C: 0.15%
pharma nasdaq grants

| -47.48% | O: -9.56% H: 2.44% C: 2.25%
nasdaq ocular global grants

FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
HUGE | News | $0.4589 -2.15% -1.21% 220K

| -20.6% | O: -1.51% H: 5.48% C: -0.56%
pharma nasdaq

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)-April 5, 2024
Published: 2024-04-05 (Crawled : 13:00) - biospace.com/
CRIS | $14.77 -1.6% -2.07% 3.9K

| 4.6% | O: 12.18% H: 6.06% C: 6.06%
nasdaq grants

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 5, 2024
Published: 2024-04-05 (Crawled : 12:30) - biospace.com/
KURA | News | $18.75 0.11% 0.16% 820K

| -10.48% | O: -4.08% H: 3.53% C: 1.34%
nasdaq grants

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 05, 2024
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
IDYA | News | $39.85 2.13% 2.08% 1.4M

| -6.0% | O: -2.42% H: 3.02% C: 2.76%
nasdaq grants

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 4, 2024
Published: 2024-04-04 (Crawled : 12:30) - biospace.com/
VSTM | $9.31 -3.12% -3.44% 79K

| -19.57% | O: 3.24% H: 1.34% C: -5.19%
nasdaq grants

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
EQ | $1.79 4.07% 4.44% 0